Gene test to pick best anti-clot drug for narrowed brain arteries
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares using a genetic test to choose between two anti-clot medications (clopidogrel and ticagrelor) versus the usual approach of giving clopidogrel alone. It aims to see if personalized treatment can better prevent strokes in people with narrowed brain arteries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You had a mini-stroke or stroke in the past 30 days caused by a narrowed artery inside the skull (30–99% blockage).
- Your doctor has recommended you take two anti-clot medicines for at least 3 months.
- You cannot take either of the study drugs (clopidogrel or ticagrelor) due to medical reasons, pregnancy, or other contraindications.
- You do not need blood thinners for other conditions like an irregular heartbeat or a mechanical heart valve.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of two blood-thinning medications (clopidogrel and rivaroxaban) is better than standard treatment (aspirin alone or aspirin plus clopidogrel) for preventing another stroke in people who have a narrowed artery inside the brain. It aims to reduce the risk of future strokes while managing bleeding risks.
This trial tests whether a genetic test can help doctors choose the best blood-thinning medicine for people with heart disease who are having a stent placed. The goal is to reduce the risk of blood clots or bleeding after the procedure.
This study compares two common blood-thinner combinations to see which one works better at preventing clots during stent placement for an unruptured brain aneurysm. It is designed for people whose bodies process these medications normally, with the goal of finding the safest and most effective option.
This trial tests whether a quick genetic test can help choose the right antiplatelet medicine for people who have had a mild stroke or a high-risk mini-stroke (TIA). The goal is to see if this personalized approach is possible in a hospital setting.
This trial tests whether choosing a blood thinner based on your DNA can prevent more heart problems. If you've had a complex heart procedure, you may be able to get a medication that works best for your body.
This study tests whether guiding antiplatelet medication with a blood test can help prevent another stroke or TIA. It looks at people who have had a mild stroke or high-risk TIA within the last 48 hours.
Hear when a new Intracranial Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.